APVOAptevo Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Aptevo Therapeutics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APVOThis | $3M#8 | 0.0x#2 | 0.5x#7 | 1.0x#2 | -74.7%#8 | -7.6%#11 | -845.0%#4 | -429.8%#11 | — | — | -93.2%#8 | — |
| GRI | $4M#1 | — | 0.4x#5 | — | -100.0%#10 | -45.7%#14 | — | -116.3%#7 | — | — | — | — |
| CVKD | $4M#2 | — | 1.0x#9 | — | — | -24.3%#12 | — | -323.5%#10 | -585.1%#3 | — | -91.9%#6 | — |
| REVB | $4M#3 | 0.0x#4 | 0.4x#4 | — | — | 40.7%#5 | — | -88.5%#3 | — | — | -87.4%#5 | — |
| TCRT | $4M#4 | — | 5.8x#14 | 757.1x#10 | -50.0%#5 | 10.8%#8 | -84500.0%#10 | -640.5%#13 | — | — | — | — |
| HCWB | $4M#5 | 0.1x#6 | 0.5x#6 | 69.4x#8 | -97.9%#9 | 73.5%#3 | -24270.7%#8 | -107.2%#5 | -99.4%#1 | 3#2 | -93.1%#7 | — |
| BIVIW | $4M#6 | — | 0.4x#3 | — | — | -25.8%#13 | — | -214.9%#8 | -1671.2%#4 | — | -7.7%#1 | — |
| SILO | $3M#7 | 0.7x#7 | 0.7x#8 | 46.7x#7 | 0.0%#2 | 3.8%#10 | -5937.0%#7 | -86.5%#2 | — | — | -78.4%#3 | — |
| GOVX | $3M#9 | — | 1.7x#12 | 1.2x#3 | -37.1%#4 | 14.1%#7 | -869.3%#5 | -1219.1%#14 | — | — | -97.6%#9 | — |
| SXTP | $3M#10 | — | 1.2x#10 | 3.0x#5 | 65.5%#1 | 7.3%#9 | -771.6%#3 | -281.7%#9 | -163.8%#2 | 6#1 | -84.4%#4 | — |
| GNPX | $3M#11 | 0.0x#3 | 0.2x#2 | — | — | 24.1%#6 | — | -109.7%#6 | — | — | — | — |
| PTPI | $3M#12 | 0.1x#5 | 3.8x#13 | 0.5x#1 | -12.2%#3 | 113.4%#1 | -90.8%#1 | 273.0%#1 | — | — | — | — |
| ONCO | $3M#13 | 0.0x#1 | 0.2x#1 | 3.1x#6 | -67.7%#7 | 76.1%#2 | -2190.0%#6 | -104.2%#4 | — | — | -99.6%#10 | — |
| JUNS | $2M#14 | — | — | 112.9x#9 | — | -254.4%#16 | -40873.2%#9 | — | — | — | — | — |
| ZVSA | $2M#15 | — | — | — | — | -165.1%#15 | — | — | — | — | -45.1%#2 | — |
| MTNB | $2M#16 | — | 1.3x#11 | 2.2x#4 | -65.6%#6 | 57.3%#4 | -635.0%#2 | -574.7%#12 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice